Trial Watch

Clinical trials covered by The Clinical Lighthouse, ranked by methodological rigor and ordered by most recent.

190 trials indexed
Favipiravir Safe, Well-Tolerated for Mild-to-Moderate Lassa Fever
PIVOTAL TRIAL · LAST 30 DAYS
Randomized Controlled Trial Nature Medicine

Favipiravir Safe, Well-Tolerated for Mild-to-Moderate Lassa Fever

A phase 2 trial in Nigeria provides pharmacokinetic data and supports favipiravir as an alternative to ribavirin for Lassa fever.

May 17, 2026 Read the trial →
Astegolimab Reduces COPD Exacerbations in Broad Patient Population Randomized Controlled Trial
American Journal of Respiratory and Critical Care Medicine

Astegolimab Reduces COPD Exacerbations in Broad Patient Population

A pooled analysis of two trials shows astegolimab significantly lowers moderate/severe exacerbation rates in patients with frequent COPD…

May 19, 2026
Armchair Positioning Improves Oxygenation in Spontaneously Breathing ICU Patients Randomized Controlled Trial
Intensive care medicine

Armchair Positioning Improves Oxygenation in Spontaneously Breathing ICU Patients

A randomized controlled trial found out-of-bed armchair positioning increased PaO2/FiO2 ratios compared to in-bed semi-recumbent positioning.

May 18, 2026
Tea Polyphenols Mitigate Brain Changes, Anxiety in Aged Diabetic Rats Randomized Controlled Trial
Brain Research

Tea Polyphenols Mitigate Brain Changes, Anxiety in Aged Diabetic Rats

A preclinical study in aged T2DM rats suggests tea polyphenol intervention may improve hippocampal structure, function, and behavior.

May 18, 2026
Digital Decision Aid Boosts STI Testing in ED for Young Adults Randomized Controlled Trial
Annals of emergency medicine

Digital Decision Aid Boosts STI Testing in ED for Young Adults

A randomized trial shows a smartphone-based tool significantly increases gonorrhea/chlamydia and pharyngeal STI testing rates in emergency department

May 17, 2026
Sternal Vibration Plus Mindfulness Improves Body Awareness, White Matter in Trauma Non-Randomized Controlled Trial
Neuropsychopharmacology

Sternal Vibration Plus Mindfulness Improves Body Awareness, White Matter in Trauma

A study in trauma-exposed adults found sternal vibration combined with mindfulness meditation enhanced interoceptive awareness and increased neurite.

May 17, 2026
Anti-C5a Antibody STSA-1002 Shows Favorable Safety, Reduced Mortality in ARDS Randomized Controlled Trial
CHEST Journal

Anti-C5a Antibody STSA-1002 Shows Favorable Safety, Reduced Mortality in ARDS

A phase 1b/2 trial indicates STSA-1002 is well tolerated and associated with lower 28-day mortality in viral pneumonia-induced ARDS.

May 17, 2026
CTBS to Right DLPFC Reduces Heavy Drinking Relapse Risk in AUD Over 12 Months Randomized Controlled Trial
Biological Psychiatry

CTBS to Right DLPFC Reduces Heavy Drinking Relapse Risk in AUD Over 12 Months

Continuous theta-burst stimulation to the right DLPFC lowered heavy-drinking relapse risk in AUD over 12 months in a randomized trial.

May 17, 2026
Dose-Sparing Polio Vaccine Matches Full-Dose Immunogenicity and Safety in Infants Randomized Controlled Trial
Lancet Infectious Diseases

Dose-Sparing Polio Vaccine Matches Full-Dose Immunogenicity and Safety in Infants

An adjuvanted inactivated poliovirus vaccine with reduced antigen content demonstrates comparable immune response and safety to standard IPV.

May 17, 2026
ED Nudge Strategy Increases Naltrexone Prescribing for Alcohol Misuse Non-Randomized Controlled Trial
Annals of emergency medicine

ED Nudge Strategy Increases Naltrexone Prescribing for Alcohol Misuse

A multicomponent emergency department protocol significantly raised naltrexone initiation for patients with alcohol-related diagnoses.

May 17, 2026
Thrombectomy Improves Functional Independence in Medium-Vessel Occlusion Stroke Randomized Controlled Trial
New England Journal of Medicine

Thrombectomy Improves Functional Independence in Medium-Vessel Occlusion Stroke

A randomized trial shows endovascular thrombectomy increases functional independence but also raises symptomatic intracranial hemorrhage risk in mediu

May 16, 2026
Multimodal AI System Matches Clinicians in Simulated Telehealth Diagnostics Randomized Controlled Trial
Nature Medicine

Multimodal AI System Matches Clinicians in Simulated Telehealth Diagnostics

A new AI system, multimodal AMIE, integrates diverse data types to achieve high diagnostic accuracy and conversational quality in simulated telehealth

May 16, 2026
Intravenous Magnesium Sulfate Reduces Rescue Analgesia for Acute Headache Randomized Controlled Trial
Annals of emergency medicine

Intravenous Magnesium Sulfate Reduces Rescue Analgesia for Acute Headache

A randomized trial finds adjunctive magnesium sulfate increases treatment success and patient satisfaction, despite pain reduction not meeting clinica

May 16, 2026
Daratumumab-VCd Improves Survival, Organ Function in AL Amyloidosis Randomized Controlled Trial
Blood

Daratumumab-VCd Improves Survival, Organ Function in AL Amyloidosis

Final ANDROMEDA analysis confirms sustained benefits of D-VCd for newly diagnosed light-chain amyloidosis, including overall survival.

May 16, 2026
Ensitrelvir Reduces COVID-19 Incidence by 6.1% in Household Contacts Randomized Controlled Trial
New England Journal of Medicine

Ensitrelvir Reduces COVID-19 Incidence by 6.1% in Household Contacts

An oral SARS-CoV-2 3C-like protease inhibitor significantly lowers infection rates when given as postexposure prophylaxis.

May 16, 2026
Abatacept Reduces Rheumatoid Arthritis Progression in Seropositive Palindromic Rheumatism Randomized Controlled Trial
Nature Medicine

Abatacept Reduces Rheumatoid Arthritis Progression in Seropositive Palindromic Rheumatism

A randomized trial indicates abatacept significantly lowers the risk of developing rheumatoid arthritis compared to hydroxychloroquine over two years.

May 16, 2026
Intracranial Stimulation Prevents Attentional Lapses in Children Randomized Controlled Trial
Nature Neuroscience

Intracranial Stimulation Prevents Attentional Lapses in Children

A new study identifies a real-time neural signature for attentional control, enabling targeted intervention to improve attention shifts.

May 15, 2026
Sutureless Robotic Partial Nephrectomy Noninferior to Renorrhaphy for Renal Tumors Randomized Controlled Trial
European urology

Sutureless Robotic Partial Nephrectomy Noninferior to Renorrhaphy for Renal Tumors

A randomized controlled trial indicates sutureless off-clamp robotic partial nephrectomy offers comparable surgical quality for cT1-2N0M0 renal tumors

May 15, 2026
Telitacicept Reduces Proteinuria in IgA Nephropathy: Phase 3 Interim Analysis Randomized Controlled Trial
New England Journal of Medicine

Telitacicept Reduces Proteinuria in IgA Nephropathy: Phase 3 Interim Analysis

A dual BAFF and APRIL antagonist significantly lowers urinary protein-to-creatinine ratio in adults with IgA nephropathy at high risk of progression.

May 15, 2026
Brepocitinib 30 mg Improves Dermatomyositis Symptoms and Reduces Glucocorticoid Need Randomized Controlled Trial
New England Journal of Medicine

Brepocitinib 30 mg Improves Dermatomyositis Symptoms and Reduces Glucocorticoid Need

A phase 3 trial shows that once-daily oral brepocitinib 30 mg significantly improves disease activity and allows for glucocorticoid tapering in adults

May 15, 2026
PsA Improvement Thresholds Vary by Baseline Disease Activity, Not Prior TNFi Exposure Randomized Controlled Trial
Annals of the Rheumatic Diseases

PsA Improvement Thresholds Vary by Baseline Disease Activity, Not Prior TNFi Exposure

Minimal clinically important improvement (MCII) thresholds in psoriatic arthritis depend on baseline disease severity, guiding personalized treatment.

May 15, 2026
Teriparatide Plus Zoledronic Acid Does Not Reduce Fracture Risk in Adults with OI Randomized Controlled Trial
JAMA

Teriparatide Plus Zoledronic Acid Does Not Reduce Fracture Risk in Adults with OI

A randomized trial found that while combination therapy increased bone mineral density, it did not lower fracture incidence.

May 15, 2026
Patient-Level Adherence Drives Enhanced Recovery Benefits in Pediatric GI Surgery Randomized Controlled Trial
JAMA Surgery

Patient-Level Adherence Drives Enhanced Recovery Benefits in Pediatric GI Surgery

A stepped-wedge trial shows that while site-level ERP implementation may not reduce length of stay, patient-level adherence does.

May 14, 2026
Lower Oxygen Saturation Target Reduces Pediatric Hospital Stay, Oxygen Therapy Randomized Controlled Trial
PubMed

Lower Oxygen Saturation Target Reduces Pediatric Hospital Stay, Oxygen Therapy

A multicenter trial suggests targeting 88% peripheral oxygen saturation in children with acute respiratory illness shortens hospitalizations.

May 14, 2026
Intra-Arterial Alteplase Improves Recovery After Successful Thrombectomy Randomized Controlled Trial
JAMA

Intra-Arterial Alteplase Improves Recovery After Successful Thrombectomy

Adjunctive thrombolysis increased 90-day functional independence by 15% but was associated with a nearly 6% increase in mortality.

May 13, 2026
Tirzepatide Reduces Major Kidney Events More Than Dulaglutide Randomized Controlled Trial
lancet. Diabetes & endocrinology

Tirzepatide Reduces Major Kidney Events More Than Dulaglutide

In patients with type 2 diabetes and cardiovascular disease, tirzepatide lowered the risk of renal outcomes by 23% over four years.

May 13, 2026
Acupuncture and Herbal Formula Improve Visual Acuity in Optic Atrophy Randomized Controlled Trial
Brain Research

Acupuncture and Herbal Formula Improve Visual Acuity in Optic Atrophy

Combining acupuncture with Jieyu Huoxue Formula reduces blood viscosity and increases peak systolic velocity to protect the optic nerve.

May 13, 2026
Deucravacitinib Modulates Over 2,500 Genes in Systemic Lupus Erythematosus Randomized Controlled Trial
Annals of the Rheumatic Diseases

Deucravacitinib Modulates Over 2,500 Genes in Systemic Lupus Erythematosus

Transcriptomic analysis shows TYK2 inhibition reverses myeloid dysregulation and increases regulatory T-cell populations in patients with lupus.

May 13, 2026
Accelerated Deep TMS Protocols Show High Remission Rates in Depression Randomized Controlled Trial
Molecular Psychiatry

Accelerated Deep TMS Protocols Show High Remission Rates in Depression

A randomized trial finds that 10-day accelerated deep TMS protocols achieve 42% to 50% remission rates, exceeding pharmacotherapy alone.

May 13, 2026
Testosterone Therapy Improves Sexual Function After Radical Prostatectomy Randomized Controlled Trial
JAMA Internal Medicine

Testosterone Therapy Improves Sexual Function After Radical Prostatectomy

A phase 2 trial shows 12 weeks of testosterone cypionate enhances libido and body composition without triggering biochemical recurrence.

May 13, 2026